The tumor was also positive for IGF-II staining, and we confirmed by western blotting that the circulating high-molecular-weight IGF-II had decreased after tumor removal, concomitant with remission of hypoglycemia (Fig. 6). The gene discussed is IGF2; the disease is neoplasm.